(BKYI) BIO-Key International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09060C3097

BKYI: Biometric, Fingerprint, Identification, Security, Software, Solutions

BIO-key International, Inc. (NASDAQ:BKYI) specializes in biometric identification technologies and enterprise-grade identity access management (IAM) solutions. The company serves a diverse range of sectors, including corporate, government, and education, both domestically and internationally. Its flagship product, BIO-key PortalGuard, is a cloud-based IAM platform designed to integrate seamlessly with SaaS applications, on-premises systems, and cloud services. PortalGuard IDaaS extends these capabilities, offering a customer-controlled, neutral-by-design identity platform. These solutions enhance security for workforces, student populations, and partner networks, enabling collaboration while minimizing risks. The company also offers BIO-key VST and WEB-key products, as well as Civil and Large-Scale ID Infrastructure solutions, which leverage fingerprint-based biometric technology for advanced identification needs. Under the SideSwipe, EcoID, and SidePass brands, BIO-key provides finger scanners tailored for both enterprise and consumer markets. Originally founded in 1993 as SAC Technologies, the company rebranded as BIO-key International, Inc. in 2002 and is headquartered in Holmdel, New Jersey.

3-Month Forecast: Based on technical and fundamental data, BIO-key International, Inc. (BKYI) is expected to experience continued volatility. The stock is currently trading at $1.22, with a 20-day average volume of 111,098 shares. The SMA 20 ($1.10) and SMA 50 ($1.37) indicate recent fluctuations, with the stock price oscillating above and below these levels. The SMA 200 ($1.30) suggests a potential resistance level. The ATR of $0.22 signals moderate price movement expectations. Fundamentally, the companys market cap of $3.25M and P/S ratio of 0.54 reflect its micro-cap status and potential sensitivity to market sentiment. Over the next three months, BKYI may face headwinds due to its high P/B ratio (29.40) and lack of profitability (P/E: 0.00). Technical support near $1.00 and resistance around $1.50 are key levels to monitor.

Additional Sources for BKYI Stock

BKYI Stock Overview

Market Cap in USD 3m
Sector Industrials
Industry Security & Protection Services
GiC Sub-Industry Systems Software
IPO / Inception 1997-02-14

BKYI Stock Ratings

Growth Rating -87.5
Fundamental -5.05
Dividend Rating 0.0
Rel. Strength -50.2
Analysts 4/5
Fair Price Momentum 0.31 USD
Fair Price DCF -

BKYI Dividends

No Dividends Paid

BKYI Growth Ratios

Growth Correlation 3m -87.7%
Growth Correlation 12m -62.5%
Growth Correlation 5y -98.7%
CAGR 5y -64.00%
CAGR/Max DD 5y -0.64
Sharpe Ratio 12m -1.17
Alpha -57.72
Beta 0.989
Volatility 79.82%
Current Volume 1390.8k
Average Volume 20d 132.3k
What is the price of BKYI stocks?
As of April 26, 2025, the stock is trading at USD 0.79 with a total of 1,390,814 shares traded.
Over the past week, the price has changed by +15.87%, over one month by -27.12%, over three months by -46.68% and over the past year by -47.04%.
Is BIO-Key International a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, BIO-Key International is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -5.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BKYI as of April 2025 is 0.31. This means that BKYI is currently overvalued and has a potential downside of -60.76%.
Is BKYI a buy, sell or hold?
BIO-Key International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy BKYI.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for BKYI stock price target?
According to ValueRays Forecast Model, BKYI BIO-Key International will be worth about 0.4 in April 2026. The stock is currently trading at 0.79. This means that the stock has a potential downside of -55.7%.
Issuer Forecast Upside
Wallstreet Target Price 3 279.7%
Analysts Target Price 3 279.7%
ValueRay Target Price 0.4 -55.7%